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Few published studies have reported the use of crude camel milk in the treatment of stomach infections, tuberculosis and cancer.
Yet, little research was conducted on the eﬀect of camel milk on the apoptosis and oxidative stress associated with human cancer.
The present study investigated the eﬀect and the underlying mechanisms of camel milk on the proliferation of human cancer cells
using an in vitro model of human hepatoma (HepG2) and human breast (MCF7) cancer cells. Our results showed that camel
milk, but not bovine milk, signiﬁcantly inhibited HepG2 and MCF7 cells proliferation through the activation of caspase-3 mRNA
and activity levels, and the induction of death receptors in both cell lines. In addition, Camel milk enhanced the expression of
oxidative stress markers, heme oxygenase-1 and reactive oxygen species production in both cells. Mechanistically, the increase in
caspase-3 mRNA levels by camel milk was completely blocked by the transcriptional inhibitor, actinomycin D; implying that
camel milk increased de novo RNA synthesis. Furthermore, Inhibition of the mitogen activated protein kinases diﬀerentially
modulated the camel milk-induced caspase-3 mRNA levels. Taken together, camel milk inhibited HepG2 and MCF7 cells survival
and proliferation through the activation of both the extrinsic and intrinsic apoptotic pathways.
1.Introduction
Apoptosis is a physiological cellular process of cell death that
is initiated by a wide variety of extrinsic and intrinsic signals
and stimuli and hence critical in several disease processes
[1]. These signals instructing the cells to undergo apoptosis
through the activation of a family of proteins known as
caspases. The intrinsic signals can initiate apoptosis through
mitochondrial oxidative stress caused by free radicals [2].
This involves a balance between proapoptotic and antiapop-
totic proteins, which enhance permeability of the mitochon-
drial outer membrane for the release of caspase activators
[1].On theother hand, the extrinsic signals induce apoptosis
through binding of cell surface death receptors, such as
tumor necrosis factor (TNF) receptor 1 (TNFR-1), TNF-
related apoptosis-inducing ligand receptor 1 (TRAILR-1,
death receptor DR4, and DR5) [1, 3]. Upon ligand binding
activated DRs recruit adaptor proteins that bind to and
activate initiator caspases, such as caspase-8 or caspase-10,
t h a ti nt u r na c t i v a t ee ﬀector caspases such as caspase-3 [4].
Caspase-3 has been identiﬁed as the major caspase that
contributes to the hallmark of apoptosis, in which activated
caspase-3 causes the cell to undergo apoptosis through the
cleavage of the key cellular proteins, such as cytoskeletal
proteins, that leads to the typical morphological changes
observed in cells undergoing apoptosis [1, 3].
Studies using transgenic and knockout mice provide
direct evidence that disruption of apoptosis can promote
tumor development and metastasis [3]. In addition, most
of clinically used cytotoxic anticancer drugs, such as dox-
orubicin, 5-Furouracil (5-FU), and cis-platinum, are able
to trigger apoptosis in susceptible tumor cells [5]. Thus,2 Journal of Biomedicine and Biotechnology
one of the strategies for inhibition of cancer development
includes attenuation of pro- and/or anti-apoptotic genes.
Therefore, the development of new chemopreventive agents
that is able to inhibit cell proliferation and induce apoptosis
in cancer cells but with less or no side eﬀects is important
and anticipated.
Chemoprevention by dietary constituents in the form
of functional food has a well-established beneﬁcial role in
health promotion and emerged as a novel approach to con-
trol cancers [6]. Camel milk is an important nutritional
source that consumed fresh or curdled and historically been
used in the treatment of diverse diseases and for the main-
tenance of good health. The main components of the camel
milk have been already determined [7], in that camel milk is
diﬀerent from other ruminant milk; having low cholesterol
and sugar, high minerals and vitamins, and high concentra-
tions of insulin [8]. Recent studies have reported that camel
milk is the most eﬀective milk among other species
against Escherichia coli, Staphylococcus aureus, Salmonella
typhimurium, and rotavirus [9, 10]. In addition, it has been
demonstrated that camel milk, in addition to secretory IgA
andIgM,alsocontainsnumerousnon-antibodycomponents
which possess antiviral activity, including lactoferrin [11].
Until recently, it is traditionally claimed that drinking camel
milk has cured and treated numerous cases of cancer, how-
ever, this proclaimed health beneﬁts of camel milk against
cancer cells have never been exposed to scientiﬁc investiga-
tion.
A very few studies have been published in the literature
regarding the medicinal properties of camel milk against
cancer. A recent work from our laboratory have shown the
ability of camel milk to signiﬁcantly inhibit the induction of
the cytochrome P4501A1 (Cyp1a1), a cancer-activating gene,
and to induce the NAD(P)H:quinone oxidoreductase 1
(NQO1), cancer chemopreventive gene in murine hepatoma
Hepa 1c1c7 cells at the transcriptional and posttranscrip-
tional levels [8]. However, none of these few studies have
investigated the eﬀect of camel milk on the apoptosis and
oxidative stress associated with human cancer cells. There-
fore, the main objectives of the current study are to (a) deter-
mine the eﬀect of camel milk on the proliferation of human
hepatocellular carcinoma HepG2 and breast cancer MCF7
cells, (b) determine the eﬀect of camel milk on apoptotic-
andoxidativestress-mediatedgenesinbothcelllines,and(c)
explore the molecular mechanisms involved.
2.MaterialsandMethods
2.1. Materials. Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM), protease inhibitor cocktail, 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazoliumbromide(MTT),4-(4-ﬂu-
orophenyl)-2-(4-methylsulﬁnylphenyl)-5-(4-pyridyl)-1H-
imidazole (SB203580), 1,4-diamino-2,3-dicyano-1,4-bis(o-
aminophenylmercapto) butadiene ethanolate (U0126), ac-
tinomycin D (Act-D), 2,7-dichloroﬂuorescein diacetate
(DCF-DA), and 1,9-pyrazoloanthrone (SP600125) were
purchased from Sigma Chemical Co. (St. Louis, MO). 100 ×
vitamin supplements were purchased from ICN Biomedicals
Canada (Montreal, QC). TRIzol reagent was purchased from
Invitrogen Co. (Grand Island, NY). The High-Capacity
cDNA reverse transcription kit and SYBR Green PCR Master
Mix were purchased from Applied Biosystems (Foster City,
CA, USA). Caspase-3 colorimetric activity kit was purchased
from Biovision (Mountain View, CA, USA). Human forward
and reverse primers were obtained from Integrated DNA
Technologies (IDT, Coralville, IA). All other chemicals were
purchased from Fisher Scientiﬁc Co. (Toronto, ON).
2.2. Collection of Camel and Bovine Milk. Camel and bovine
milk samples were collected early morning daily from farm
200km away from Riyadh city, Saud Arabia. The udders of
each camel and bovine were washed and dried with a clean
towel, and the teats were then swabbed with 70% alcohol.
The milk was collected from camels and bovines by hand
milking as normally practiced by the farmers, and then col-
lectedandstoredinsterilescrewbottle.Themilkwasallowed
to ﬂow directly into stainless steel containers and then trans-
ferredtoglassvials.Themilksamplesweretransportedtothe
laboratory as soon as practical (<4h). The milks were then
lyophilized and kept in the frozen state at −80◦C until
use.
2.3. Cell Culture and Treatments. Human hepatoma HepG2
and breast cancer MCF7 cells (American Type Culture Col-
lection, Manassas, VA) were maintained in DMEM, with
phenol red supplemented with 10% heat-inactivated fetal
bovine serum, 20μM L-glutamine, 100IU/mL penicillin G,
10μg/mL streptomycin, 0.1mM nonessential amino acids,
and vitamin supplement solution. Cells were grown in
75cm2 tissue culture ﬂasks at 37◦Cu n d e ra5 %C O 2 humid-
iﬁed environment.
HepG2 and MCF7 cells were plated onto 12-well cell cul-
tureplatesinDMEMculturemediaforcaspase-3activityand
m R N Aa s s a y s .M i l kw a sp r e p a r e df r e s hj u s tb e f o r ee a c he x -
periment and dissolved in dimethyl sulfoxide (DMSO). In all
experiments, DMSO concentrations did not exceed 0.05%
(v/v).
2.4. Cell Proliferation Assay. The capacity of camel milk to
alter HepG2 and MCF7 cell proliferation and growth was
determined by measuring the capacity of reducing enzymes
present in viable cells to convert MTT salt to formazan
crystalsasdescribedpreviously[12].Twenty-fourhoursafter
incubating the cells with the tested camel and bovine milks
in a 96-well cell culture plate at 37◦Cu n d e ra4 %C O 2
humidiﬁed incubator, the media were removed and a 100μL
of serum-free medium containing 1.2mM of MTT dissolved
in phosphate-buﬀered-saline (PBS), pH 7.4, was added to
eachwell.TheplatewasthenincubatedinaCO2 incubatorat
37◦C for 2h. The media were then decanted oﬀ by inverting
theplate;anda100μLofisopropylalcoholwasaddedtoeach
well, with shaking for 1h to dissolve the formazan crystals.
The color intensity in each well was measured at wavelength
of 550 using BIO-TEK Instruments EL 312e microplate
reader,Bio-TekInstruments(Winooski,VT).Thepercentage
of cell viability was calculated relative to control wells des-
ignated as 100% viable cells using the following formula:
(Atreated)/(Acontrol) ×100%.Journal of Biomedicine and Biotechnology 3
Table 1: Primers sequences used for real-time PCR reactions.
Gene Forward primer Reverse primer
CASPASE-3 GAGTGCTCGCAGCTCATACCT CCTCACGGCCTGGGATTT
p53 GCCCCCAGGGAGCACTA GGGAGAGGAGCTGGTGTTG
BCl2 CATGTGTGTGGAGAGCGTCAA GCCGGTTCAGGTACTCAGTCA
DR4 AGTACATCTAGGTGCGTTCCTG GTGCTGTCCCATGGAGGTA
HO-1 ATGGCCTCCCTGTACCACATC TGTTGCGCTCAATCTCCTCCT
NQO1 CGCAGACCTTGTGATATTCCAG CGTTTCTTCCATCCTTCCAGG
β-actin TATTGGCAACGAGCGGTTCC GGCATAGAGGTCTTTACGGATGTC
2.5. Determination of Reactive Oxygen Species (ROS) Pro-
duction. Intracellular ROS was analyzed ﬂuorometrically by
measuring the oxidation of a non-ﬂuorescent probe 2,7-
dichloroﬂuorescein diacetate (DCF-DA) to a ﬂuorescent
metabolite dichloroﬂuorescein (DCF) by the mitochondrial
ROS as described previously with slight modiﬁcations [13].
Brieﬂy, HepG2 cells grown to 90% conﬂuence in 96-well
cell culture plates were treated for 24h with various con-
centrations of camel milk. Thereafter, cells were washed
with PBS before incubated for 30min in fresh media con-
taining 10μM DCF-DA. The ﬂuorescence was directly mea-
sured using excitation and emission wavelengths of 485 and
535nm, respectively, using POLARstar Omega, BMG Lab-
Tech (Oﬀenburg, Germany).
2.6. RNA Extraction and cDNA Synthesis. Total RNA was
isolated using TRIzol reagent (Invitrogen) according to the
manufacturer’s instructions and quantiﬁed by measuring
the absorbance at 260nm. RNA quality was determined by
measuring the 260/280 ratio. Thereafter, ﬁrst strand cDNA
was synthesized using the High-Capacity cDNA reverse
transcription kit (Applied Biosystems) according to the
manufacturer’s instructions. Brieﬂy, 1μgo ft o t a lR N Af r o m
each sample was added to a mix of 2.0μL of 10x reverse
transcriptase buﬀer, 0.8μL of 25x dNTP mix (100mM),
2.0μL of 10x reverse transcriptase random primers, 1.0μLo f
MultiScribe reverse transcriptase, and 3.2μLo fn u c l e a s e - f r e e
water. The ﬁnal reaction mix was kept at 25◦C for 10min,
heated to 37◦C for 120min, heated for 85◦Cf o r5 s ,a n d
ﬁnally cooled to 4◦C[ 14].
2.7. Quantiﬁcation of mRNA Expression by Real-Time Poly-
merase Chain Reaction (RT-PCR). Quantitative analysis of
speciﬁc mRNA expression was performed by RT-PCR by
subjecting the resulting cDNA to PCR ampliﬁcation using
96-well optical reaction plates in the ABI Prism 7500 System
(Applied Biosystems). The 25-μL reaction mix contained
0.1μLo f1 0μM forward primer and 0.1μLo f1 0μMr e v e r s e
primer (40nM ﬁnal concentration of each primer), 12.5μL
of SYBR Green Universal Master Mix, 11.05μLo fn u c l e a s e -
free water, and 1.25μLo fc D N As a m p l e .T h ep r i m e r s
used in the current study (Table 1)w e r ep u r c h a s e df r o m
Integrated DNA Technologies (IDT, Coralville, IA). Assay
controls were incorporated onto the same plate, namely, no-
template controls to test for the contamination of any assay
reagents. The RT-PCR data was analyzed using the relative
geneexpression(i.e.,ΔΔCT)methodasdescribedpreviously
[15]. Brieﬂy, the data are presented as the fold change in
geneexpressionnormalizedtotheendogenoushousekeeping
gene (β-actin) and was determined using the equation fold
change = 2−Δ(ΔCt),w h e r eΔCt = Ct(target) − Ct(β-actin) and
Δ(ΔCt) = ΔCt(treated) −ΔCt(untreated).
2.8. Determination of Caspase-3 Activity. Caspase-3 activity
was measured colorimetrically using the CaspACE assay sys-
tem purchased from Biovision (Mountain View, California,
USA) according to the manufacturer’s instructions. Brieﬂy,
HepG2 cells plated onto 12-well cell culture plate were
t r e a t e df o r2 4hw i t hd i ﬀerent concentrations of camel milk.
Thereafter, HepG2 ell were then collected by trypsinization
and cell pellets were resuspended in ice-cold cell lysis buﬀer
and incubated for 10min on ice. The supernatant obtained
by centrifugation for 10min at 10,000×ga t4 ◦Cw a s
transferred to a fresh tube and stored at −20◦C until use. For
measuring caspase-3 activity, approximately 30μgp r o t e i n
was incubated with 200μM enzyme-speciﬁc colorimetric
caspase-3 substrate I, acetyl-Asp-Glu-Val-Asp p-nitroanilide
(Ac-DEVD-pNA) at 37◦C for 2hr. Caspase-3 activity was
assessed by measuring absorbance at a wavelength of 405nm
with a plate reader (Bio-Tek Instruments, Winooski, VT).
2.9. Statistical Analysis. All results are presented as mean ±
SEM. The comparative analysis of the results from various
experimental groups with their corresponding controls was
performed using SigmaStat for Windows, Systat Software
Inc., (San Jose, CA). One-way analysis of variance (ANOVA)
followed by Student-Newman-Keul’s test was carried out
to assess which treatment groups showed a signiﬁcant
diﬀerence from the control group. The diﬀerences were
considered signiﬁcant when P<0.05.
3. Results
3.1. Eﬀect of Camel Milk on HepG2 Cell Proliferation. To
determine the capacity of camel milk to inhibit cancer cell
growth and proliferation, HepG2 cells were treated for 24h
with increasing concentrations of camel or bovine milk (0,
2.5, 5, 10, 20, 40, and 80mg/mL), thereafter cell viability
and proliferation were determined by MTT assay. Figure 1
shows that survival of HepG2 cells was signiﬁcantly reduced
following incubation with camel milk in a concentration-
dependent manner, as compared to bovine milk which did
not alter cell growth at all concentrations tested (Figure 1),
suggesting that camel milk has tumor cell selectivity. The
calculated IC50 for camel milk is approximately 76mg/mL.4 Journal of Biomedicine and Biotechnology
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Figure 1: Eﬀect of camel and bovine milks on HepG2 cell prolifera-
tion.Cellswereincubatedwithvariousconcentrationsofcameland
bovine milk for 24h, thereafter cell proliferation was assessed using
the MTT assay. Values are presented as percentage of the control
(mean ± SEM, n = 8). +P < 0.05 compared to control (0mg/mL).
Based on these results, the camel milk concentrations of
2.5, 5, 10, and 20mg/mL were chosen to be utilized in all
subsequent experiments.
3.2. Eﬀect of Camel Milk on the mRNA Expression Level of
Apoptotic Genes in HepG2 Cells. To examine whether the
inhibitory eﬀect of camel milk on HepG2 cells prolifera-
tion and growth is an apoptotic-mediated mechanism, we
determined the capacity of camel milk to modulate the
expression of apoptotic and antiapoptotic genes. For this
purpose, HepG2 cells were incubated for 6h with increasing
concentrations of camel milk (2.5, 5, 10, and 20mg/mL),
as determined by the MTT assay (Figure 1), thereafter
Caspase-3, p53, Bcl2, and DR4 mRNA expression levels were
determined by RT-PCR. Figure 2 shows that camel milk
signiﬁcantly induced caspase-3 and DR4 mRNA expression
levels in a concentration-dependent manner (Figures 2(a)
and 2(d)). The maximum induction was observed at the
highest concentrations tested (20mg/mL) by approximately
7and10folds,respectively.Ontheotherhand,nosigniﬁcant
changes in p53 and Bcl2 mRNA levels in response to camel
milk were observed (Figures 2(b) and 2(c)).
3.3. Eﬀect of Camel Milk on the Expression of Oxidative Stress
Genes in HepG2 Cells. To further explore whether camel
milk-induced apoptotic genes is associated with induction
of oxidative stress markers in HepG2 cells, we examined the
eﬀectofcamelmilkonhemeoxygenase1(HO-1)andNQO1
mRNAs and ROS production as oxidative stress marker.
For this purpose, HepG2 cells were incubated for indicated
time points with increasing concentrations of camel milk,
thereafter HO-1 and NQO1 mRNA and ROS production
were measured by RT-PCR and DCF assay, respectively.
Figure 3(a) shows that camel milk signiﬁcantly induced HO-
1 mRNA levels only at the higher concentrations tested, 10
and 20mg/mL, by approximately 3 and 4 folds, respectively.
In addition, while camel milk did not alter the expres-
sion of NQO1 mRNA levels (Figure 3(b)), it signiﬁcantly
increased the ROS production at all concentrations tested
in a concentration-dependent manner (Figure 3(c))w i t ha
maximum induction of 10-fold achieved by 20mg/mL camel
milk treatment.
3.4. Eﬀect of Camel Milk on the Apoptotic and Oxidative
StressGenesin MCF7Cells. To examine whethercamelmilk-
mediated apoptosis and oxidative stress is cancer-speciﬁc or
could be extrapolated to other cancer types. For this purpose
we determined the ability of camel milk to modulate the
expression of apoptotic and oxidative stress genes in human
breast cancer cells, MCF7 cells. Therefore, MCF7 cells were
incubated with same concentration of camel milk for 6h,
thereafter Caspase-3, DR4, and HO-1 mRNA levels (the
markers that showed signiﬁcant alterations in HepG2 cells)
were determined by RT-PCR. Our results showed that camel
milk, in a manner similar to what was observed with
HepG2 cells (Figure 4), signiﬁcantly induced Caspase-3 and
DR4 mRNA expression levels in MCF7 cells in a con-
centration-dependent manner (Figures 4(a) and 4(b)),
however; induced HO-1 mRNA levels only at the highest
concentration tested (20mg/mL) see Figure 4(c).
3.5.EﬀectofCamelMilkonCaspase-3ActivityinHepG2Cells.
In order to examine whether the induction of caspase-3
mRNA by camel milk in HepG2 cells is translated into
a functional catalytic activity, we examined the eﬀect of
camel milk on caspase-3 activity. For this purpose, HepG2
cells were treated for 24h with increasing concentrations
of camel milk; thereafter, caspse-3 activity was determined
colormetrically using biovision kit as described in Section 2
Figure 5 shows that camel milk increased the caspase-3
activity only at the higher concentrations, 10 and 20mg/mL
by approximately 2.5 and 6.5 folds, respectively.
3.6. Eﬀect of the Transcription Inhibitor, Act-D, on the Induc-
tion of Caspase-3 mRNA by Camel Milk in HepG2 Cells. To
further investigate whether the increase in caspase-3 mRNA
b yc a m e lm i l ki nH e p G 2c e l l si sa t t r i b u t e dt oa ni n c r e a s e
in the de novo RNA synthesis, HepG2 cells were treated for
6h with camel milk (20mg/mL) in the presence or absence
of 5μg/mL Act-D, an RNA synthesis inhibitor. Caspase-3
mRNA was then quantiﬁed by RT-PCR. If camel milk
increased the amount of caspase-3 mRNA through increas-
ing its de novo RNA synthesis under these circumstances,
we would expect to observe a decrease in the content of
Caspase-3 mRNA after the inhibition of its RNA synthesis.
Figure 6 shows that pretreatment of the cells with Act-
D did not signiﬁcantly alter the constitutive expression of
Caspase-3 mRNA as compared to untreated cells. However,
the induction of Caspase-3 mRNA by camel milk was
completely abolished by Act-D, suggesting that camel milk
increases the Caspase-3 mRNA level by increasing its de novo
RNA synthesis.
3.7. Eﬀect of the Mitogen Activated Protein Kinases (MAPKs)
InhibitorsontheInductionofCaspase-3mRNAbyCamelMilk
in HepG2 Cells. To further investigate whether activation of
the MAPK pathways is required for apoptotic cell death byJournal of Biomedicine and Biotechnology 5
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Figure 2: Eﬀect of camel milk on apoptotic markers Caspase-3 (a), p53 (b), BcL2 (c), and DR4 (d) mRNA levels in HepG2 cells. HepG2 cells
were treated for 6h with a various concentrations of camel milk (2.5, 5, 10, and 20mg/mL). Thereafter, total RNA was isolated using TRIzol
reagent, and the mRNA levels of Caspase-3, p53, BcL2, and DR4 were quantiﬁed using RT-PCR normalized to β-actin housekeeping gene as
described in Section 2. Duplicate reactions were performed for each experiment, and the values presented are the means ± SEM (n = 6) of
three independent experiments. +P < 0.05 compared to control (0mg/ml).
camelmilk,HepG2cellswerepretreatedfor2hwithc-JunN-
terminal kinases (JNK) inhibitor, SP600125 (10μM), Extra-
cellular signal-regulated kinases (ERK) inhibitor, U0126
(10μM), and p38 MAPK inhibitor, SP203580 (10μM) [16]
prior to the addition of camel milk (10mg/mL) for addi-
tional 6h, thereafter capspase-3 mRNA was quantiﬁed by
RT-PCR. The eﬀective concentrations of these inhibitors
were selected by dose-response assays in order to prevent
cytotoxicity (data not shown).
If camel milk-induced caspase-3 mRNA is mediated
through MAPKs signaling pathways, inhibition of MAPK
wouldpreventcamelmilk-mediatedeﬀectsoncaspase-3gene
expression. Figure 7 shows that pretreatment of the cells
with MAPK inhibitors alone slightly but not signiﬁcantly de-
creases the basal expression level of caspase-3 mRNA
(Figure 7).Importantly,theinductionofcapsase-3mRNAby
camel milk in HepG2 cells was signiﬁcantly decreased by
both the JNK and p38 MAPKs inhibitors, SP600125 and
SB203580, by approximately 100% and 80%, respectively,
whereas further potentiated by U0126, ERK inhibitor
(Figure 7).
4. Discussion
The current study provides, to our knowledge, the ﬁrst
mechanistic evidence for the ability of camel milk to signif-
icantly inhibit the growth and proliferation of human liver
HepG2 and breast MCF7 cancer cells through apoptotic-
and oxidative stress-mediated mechanisms. In this study,
molecular mechanisms underlying camel milk-induced cell
growth inhibition and apoptosis were measured on the
following perspectives: (a) the activation of caspase-3 at the
mRNA and activity levels, (b) the activation of DR4, (c) the
accumulationofintracellularROS,and(d)theroleofMAPK
signaling pathways.
Apoptosis is a tightly regulated process under the con-
trol of several signaling pathways, such as caspases and
mitochondrial pathways [4, 17]. Particularly, caspase-3 is
an important proapoptotic protein within the extrinsic and
intrinsic apoptotic pathways [3]. Activation of caspase-3
plays a central role in the initiation of apoptosis, which
requires the activation of initiator caspases, such as caspase-
8 or -9, in response to proapoptotic signals [3]. Induction of
apoptosis withgeneration ofROS by cancerchemoprotective
agents, such as doxorubicin [2], not only induces cancer
cell death but also causes DNA damage and genomic insta-
bility [18]. However, most of these cancer chemoprotective
therapies are cytotoxic and their use is associated with
toxicities. Thus, the development of new chemopreventive
agents able to inhibit cell proliferation and induce apoptosis
in cancer cells but with less or no side eﬀects is important
and anticipated.6 Journal of Biomedicine and Biotechnology
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Figure 3: Eﬀect of camel milk on oxidative stress markers HO-
1 (a) and NQO1 (b) mRNA levels, and ROS (c) production in
HepG2 cells. (a) and (b) HepG2 cells were treated for 6h with a
various concentrations of camel milk (2.5, 5, 10, and 20mg/mL).
Thereafter, total RNA was isolated using TRIzol reagent and the
mRNA levels of HO-1 and NQO1 were quantiﬁed using RT-PCR
normalized to β-actin housekeeping gene as described Section 2.
Duplicate reactions were performed for each experiment, and
the values presented are the means ± SEM (n = 6) of three
independent experiments. +P < 0.05 compared with untreated
cells. (c) HepG2 cells were treated for 24h with a various
concentrations of camel milk (2.5, 5, 10, and 20mg/mL).
Thereafter, cells were incubated with DCF-DA (10μM) for 1h.
DCF formation was measured ﬂuorometrically using excita-
tion/emission wavelengths of 484/535nm. Values are presented as
means ± SEM, n = 8. +P<0.05, compared to control
(0mg/mL).
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Figure 4: Eﬀect of camel milk on apoptotic and oxidative stress
markers Caspase-3 (a), DR4 (b), and HO-1 (c) mRNA levels
in MCF7 cells. MCF7 cells were treated for 6h with a various
concentrationsofcamelmilk(2.5,5,10,and20mg/mL).Thereafter,
total RNA was isolated using TRIzol reagent and the mRNA levels
of Caspase-3, DR4, and HO-1 were quantiﬁed using RT-PCR
normalized to β-actin housekeeping gene as described Section 2.
Duplicate reactions were performed for each experiment, and the
valuespresentedarethemeans ±SEM(n = 6)ofthreeindependent
experiments. +P<0.05 compared to control (0mg/mL).
Previous study from our laboratory have reported the
ability of camel milk to inhibit the expression of CYP1A1,
a cancer-activating gene, and to induce the expression of
NQO1, a chemoprotective gene, in murine hepatoma Hepa
1c1c7 cells [8]. However, the chemoprotective eﬀect of camel
milk against human cancer cells had not been examinedJournal of Biomedicine and Biotechnology 7
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Figure 5: Eﬀect of camel milk on apoptotic Caspase-3 catalytic
activity in HepG2 cells. HepG2 cells were treated for 24h with a
various concentrations of camel milk (2.5, 5, 10, and 20mg/mL).
Thereafter,caspase-3 activity was determined calorimetrically using
sing the CaspACE assay system purchased from Biovision. Caspase-
3 activity was assessed by measuring absorbance at a wavelength of
405nm with a plate reader (Bio-Tek Instruments, Winooski, VT).
Values are presented as mean ± SEM (n = 6). +P<0.05 compared
to control (0mg/mL).
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Figure 6: Eﬀect of RNA synthesis inhibitor Act-D on the induction
Caspase-3 activity by camel milk in HepG2 cells. HepG2 cells were
treated with 5μg/mL Act-D, a RNA synthesis inhibitor, 30min
before exposure to camel milk (20mg/mL) for additional 6h. The
amount of Caspase-3 mRNA was quantiﬁed using RT-PCR and
normalized to β-actin housekeeping gene. Duplicate reactions were
performed for each experiment, and the values presented are the
means ± SEM (n = 6) of three inv experiments. +P < 0.05
compared with control; ∗P<0.05 compared to same treatment in
the absence of Act-D.
before. Therefore, to model the in vivo situation, human
hepatoma HepG2 and breast cancer MCF7 cell lines were
used in the current study to predict human responses to
camel milk by investigating the capacity of camel milk to
inhibit HepG2 and MCF7 cells growth and proliferation and
explore the role of apoptosis in camel milk-mediated eﬀect.
Initially, we have assessed the potential eﬀect of camel
milk to suppress the growth and proliferation of HepG2 cells
using the MTT assay since this assay has been demonstrated
to correlate with clinical outcome [19]. We demonstrated
herethatcamelmilk,butnotbovine,wasabletosigniﬁcantly
suppress HepG2 cell proliferation and growth (Figure 1).
Importantly, the camel milk-mediated eﬀect in HepG2 cells
is attributed to induction of apoptotic signaling pathway,
as evidenced by activation of caspase-3 mRNA and activ-
ity levels without changes in the expression of p53 and
Bcl2 (Figure 2), suggesting a p53-independet mechanism.
Although p53 gene was the ﬁrst tumor suppressor gene
linked to apoptosis, DNA-induced apoptosis was shown
in cell lines lacking p53 expression or mutated p53 [20].
Furthermore, studies using transgenic and knockout mice
have reported the ability of several chemotherapeutic agents,
such as curcumin [21]a n dd o x o r u b i c i n[ 2], to induce
apoptosis through a p53-independent pathway.
C ells urfac ed eathr ec ept o rsha v ebee nid e ntiﬁedasmajo r
pathway in apoptotic induction [22, 23], which involves the
ligation of the TNF/Fas-receptor with its ligand followed by
caspases activation [24]. Therefore, we have tested whether
DRs are involved in camel milk-mediated eﬀects by measur-
ing the expression of DR4. In this regard, we have shown
here that induction of DR4 mRNA in response to camel milk
signiﬁcantly contributes to the activation of caspase-3. Our
results are in agreement with previous observations demon-
strated that antitumor agents, such as ET, doxorubicin, Ara-
C, 5-FU, and cis-platinum, or irradiation can upregulate the
expressions of DR4 and DR5 in acute leukemia, multiple
myeloma, and solid tumor cell lines [23, 25].
Activation of caspase-3 has also been shown to be medi-
ated through mitochondrial ROS production [26]. Our data
provide evidence that the apoptotic cell death induced by
camelmilkinHepG2cellsisassociatedwithROSgeneration.
This is in agreement with previous ﬁndings that ROS per
se are potent inducers of apoptosis [27]. Taken together, it
would suggest that induction of ROS in response to camel
milk triggers caspase-3 activation which is a direct eﬀect and
is not caused by a decrease in the levels of Bcl-2, a protein
possesses antioxidant function and blocks ROS production
[28], as no changes in its mRNA expression was observed
(Figure 2). Importantly, similar pattern of caspase-3, DR4,
and HO-1 mRNAs induction was observed in human breast
cancer MCF7 cells (Figure 4), suggesting that camel milk-
mediatedeﬀectisnotspeciﬁctoHepG2cells.Takentogether,
these results indicate that HepG2 and MCF7 cells are sus-
ceptible to caspase-3-induced cell death, as overexpression of
caspase-3 induced direct cytotoxicity to the cells.
Mechanistically, we have shown here that the ability of
camel milk to induce caspase-3 gene is a transcriptional
mechanism. This was supported by the ability of the tran-
scription inhibitor, Act-D, to signiﬁcantly block the newly
synthesized caspase-3, but not existing, mRNAs (Figure 6),
suggesting a requirement of de novo RNA synthesis for the
induction of caspase-3 mRNA by camel milk [29]. On the
other hand, MAPK cascades play important roles in cell
death and survival signaling [30, 31]. Thus, we have exam-
ined and compared their role in casepase-3 mRNA expres-
sion by camel milk using speciﬁc inhibitors of JNK, ERK,
and p38 MAPKs. Inhibition of JNK and p38 MAPK signif-
icantly decreased activation of caspase-3 mRNA in HepG2 in8 Journal of Biomedicine and Biotechnology
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Figure 7: Eﬀect of MAPKs inhibitors on camel milk mediated induction of caspase-3 mRNA levels in HepG2 cells. HepG2 cells were pre-
treated with for 2h with JNK inhibitor, SP600125, p38 inhibitor, SB203580, and ERK inhibitor, U0126, before the addition of camel milk
(10mg/mL) for additional 6h. Thereafter, total RNA was isolated using TRIzol reagent and the mRNA levels of Caspase-3 were quantiﬁed
using RT-PCR normalized to β-actin housekeeping gene as described Section 2. Duplicate reactions were performed for each experiment,
and the values presented are the means ± SEM (n = 6) of three independent experiments. +P<0.05 compared to untreated cells; ∗P<0.05
compared to camel milk-treated cells.
response to camel milk, whereas inhibition of ERK signaling
pathway enhanced the camel milk-induced activation of
caspase-3 mRNA. These ﬁnding support previous observa-
tions that ERK plays a role in cell survival [32] and conﬁrm
the proapoptotic eﬀect of JNK [4].
Although the potential mediators in camel milk involved
in apoptosis were not examined in this study, several
previous studies have reported that camel milk contains con-
siderably higher amounts of antioxidant vitamins, such as E
and C, in comparison to bovine milk [33], lyzosomes [34],
lactoferrins [34, 35], and immunoglobulines [35]. Among
these mediators, lactoferrin, an iron-binding glycoprotein,
is known to exert in vitro and in vivo antitumor activity
[36]. In this context, it has been recently reported that lacto-
ferrin inhibits the development of cancer through inhibit-
ing CYP1A1 activation in 7,12-dimethylbenz[a]anthracene
(DMBA-) induced hamster buccal pouch carcinoma model.
Taken together, the results obtained from our laboratory and
previously published reports, we speculate that lactoferrin
could be responsible for camel milk-mediated eﬀect.
In conclusion, to our knowledge, this will be the ﬁrst
study investigating the molecular mechanisms that govern
the eﬀect of camel milk on human cancer cells. This study
clearly demonstrated that camel milk induces apoptosis in
HepG2 and MCF7 cells through apoptotic- and oxidative-
stress-mediated mechanisms. These results are of potential
clinical signiﬁcance to humans in that it uncovers the molec-
ular mechanism involved and could explain the anecdotal
evidenceforthesuccessfuluseofcamelmilkinthetreatment
of various medical conditions.
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